ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04512	ECM-receptor interaction	11/101	79/7206	9.68305794202e-09
ko04974	Protein digestion and absorption	11/101	96/7206	7.76225904578e-08
ko04510	Focal adhesion	13/101	240/7206	2.69828643868e-05
ko05144	Malaria	6/101	45/7206	3.41721448624e-05
ko05410	Hypertrophic cardiomyopathy (HCM)	8/101	100/7206	7.24535482914e-05
ko04151	PI3K-Akt signaling pathway	16/101	390/7206	9.18486127222e-05
ko05146	Amoebiasis	7/101	99/7206	0.0004473116487
ko04933	AGE-RAGE signaling pathway in diabetic complications	8/101	135/7206	0.000576635628082
ko05414	Dilated cardiomyopathy	7/101	112/7206	0.000938660279983
ko00020	Citrate cycle (TCA cycle)	4/101	35/7206	0.00136360897023
ko04260	Cardiac muscle contraction	6/101	98/7206	0.00243017349207
ko00620	Pyruvate metabolism	4/101	46/7206	0.00377828965919
ko04020	Calcium signaling pathway	10/101	265/7206	0.0038446975925
ko05200	Pathways in cancer	15/101	492/7206	0.0040852808705
ko05416	Viral myocarditis	4/101	55/7206	0.00717493364724
ko01200	Carbon metabolism	6/101	128/7206	0.008951693783
ko04371	Apelin signaling pathway	7/101	177/7206	0.0118739026028
ko04390	Hippo signaling pathway	7/101	188/7206	0.0161105255293
ko00010	Glycolysis / Gluconeogenesis	4/101	74/7206	0.019795998523
ko04921	Oxytocin signaling pathway	7/101	209/7206	0.0270061562861
ko05220	Chronic myeloid leukemia	4/101	85/7206	0.0310303423033
ko04022	cGMP-PKG signaling pathway	7/101	216/7206	0.0315473183795
ko04922	Glucagon signaling pathway	5/101	128/7206	0.0334706585533
ko04380	Osteoclast differentiation	5/101	134/7206	0.0395867921265
ko04930	Type II diabetes mellitus	3/101	54/7206	0.0396165873156
ko05321	Inflammatory bowel disease (IBD)	3/101	56/7206	0.0434038652549